Bolt Biotherapeutics Inc. (BOLT)
NASDAQ
Closed
Aug 21, 2026
Day's Range
3.2052 wk Range
3.13Overview - BOLT - Bolt Biotherapeutics Inc.
Key Statistics
Valuation
Enterprise Value
11.08M
P/E (Trailing)
‪-0.20‬
P/E (Forward)
‪-0.18‬
PEG Ratio
‪0.0079‬
Price / Sales (TTM)
‪1.50‬
Price / Book
‪0.55‬
EV / EBITDA
‪-0.40‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-151,320.00%‬
Return on Assets
‪-30.72%‬
Return on Equity
‪-111.64%‬
Ownership
Shares Outstanding
1.92M
Float
1.67M
Short % of Shares Outstanding
‪0.20%‬
Held by Insiders
‪3.46%‬
Held by Institutions
‪27.91%‬
Price stats
Beta
‪1.08‬
50-Day Avg
‪3.96‬
200-Day Avg
‪4.78‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - BOLT - Bolt Biotherapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- BOLTNASDAQBolt Biotherapeutics Inc.7.06MMarket Cap-48.54%52-week change-0.21P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt65.04BMarket Cap+34.86%52-week change39.69P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc31.60BMarket Cap-87.81%52-week change41.15P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE29.28BMarket Cap+9.87%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.61BMarket Cap+24.84%52-week change19.38P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.93BMarket Cap+41.98%52-week change-21.56P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.91BMarket Cap+12.29%52-week change180.27P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - BOLT - Bolt Biotherapeutics Inc.
About
Bolt Biotherapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies for cancer treatment. The company harnesses the immune system through its proprietary Boltbody Immune-Stimulating Antibody Conjugate (ISAC) platform, which combines tumor-targeting antibodies with…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
